Menu
In the 1970s, agrochemical company Monsanto developed one of the most potent chemical herbicides on the market: glyphosate. When the manufacturer began marketing the product as Roundup, it became one of the most popular herbicides in history, available for commercial and residential use.
But in 2015, the cancer research team at the World Health Organization classified glyphosate–Roundup’s active ingredient–as a probable human carcinogen. This means exposure to the chemical carries a risk of cancer. Scientists uncovered a specific link to non-Hodgkin’s lymphoma, which damages the body’s germ-fighting immune system.
Victims Come Forward
Since the WHO’s report on Roundup and glyphosate, thousands of cancer patients have come forward alleging that exposure to the chemical caused their illness. These victims rightfully demanded accountability and compensation from Bayer, which acquired Monsanto in 2018.
Bayer has already paid billions to plaintiffs, including a $10 billion settlement in 2020 that ended thousands of lawsuits. Before that, a jury awarded a California couple $2 billion. These are just a small sample of favorable outcomes for victims.
Roundup’s Entire Formula Under the Microscope
In 2021, Bayer announced it would remove glyphosate from its residential weed killer, effective January 2023.
In attempting to avoid accountability for their dangerous product, Bayer points to reports from the FDA and EPA that insist glyphosate is not harmful to humans. However, current and future litigation focuses on the dangers of Roundup’s entire formula–not just glyphosate.
Since 2016, Duncan|Stubbs has represented over 20,000 clients who allege their cancer diagnosis was caused by prolonged exposure to Roundup. Each and every case is handled and fought with the utmost care, led by some of the most respected and experienced lawyers in the field.
We understand that every story is different, and so a personalized legal strategy is key. There is no one-size-fits-all mentality at Duncan|Stubbs.
Finally, we have a proud reputation of refusing to back down until our clients receive maximum recoveries. Litigation will continue until we go to trial, or Bayer pays clients what they’re owed–no less.
Duncan|Stubbs Roundup lawsuits are pending around the country, and we are currently accepting new cases to ensure as many victims as possible receive compensation.
As always, Duncan|Stubbs charges nothing for its services unless a settlement is awarded.
Free Case Review
No fee unless you receive compensation.
"*" indicates required fields